Inhibition of platelet aggregation by activation of platelet intermediate conductance Ca2+ -activated potassium channels
- PMID: 35867883
- DOI: 10.1111/jth.15827
Inhibition of platelet aggregation by activation of platelet intermediate conductance Ca2+ -activated potassium channels
Abstract
Background: Within the vasculature platelets and endothelial cells play crucial roles in hemostasis and thrombosis. Platelets, like endothelial cells, possess intermediate conductance Ca2+ -activated K+ (IKCa ) channels and generate nitric oxide (NO). Although NO limits platelet aggregation, the role of IKCa channels in platelet function and NO generation has not yet been explored.
Objectives: We investigated whether IKCa channel activation inhibits platelet aggregation, and per endothelial cells, enhances platelet NO production.
Methods: Platelets were isolated from human volunteers. Aggregometry, confocal microscopy, and a novel flow chamber model, the Quartz Crystal Microbalance (QCM) were used to assess platelet function. Flow cytometry was used to measure platelet NO production, calcium signaling, membrane potential, integrin αIIb /β3 activation, granule release, and procoagulant platelet formation.
Results: Platelet IKCa channel activation with SKA-31 inhibited aggregation in a concentration-dependent manner, an effect reversed by the selective IKCa channel blocker TRAM-34. The QCM model along with confocal microscopy demonstrated that SKA-31 inhibited platelet aggregation under flow conditions. Surprisingly, IKCa activation by SKA-31 inhibited platelet NO generation, but this could be explained by a concomitant reduction in platelet calcium signaling. IKCa activation by SKA-31 also inhibited dense and alpha-granule secretion and integrin αIIb /β3 activation, but maintained platelet phosphatidylserine surface exposure as a measure of procoagulant response.
Conclusions: Platelet IKCa channel activation inhibits aggregation by reducing calcium-signaling and granule secretion, but not by enhancing platelet NO generation. IKCa channels may be novel targets for the development of antiplatelet drugs that limit atherothrombosis, but not coagulation.
Keywords: intermediate conductance Ca2+-activated K+ channels; nitric oxide; platelet aggregation; platelets; thrombosis.
© 2022 International Society on Thrombosis and Haemostasis.
Comment in
-
Can KCa3.1 channel activators serve as novel inhibitors of platelet aggregation?J Thromb Haemost. 2022 Nov;20(11):2488-2490. doi: 10.1111/jth.15863. J Thromb Haemost. 2022. PMID: 36271464 No abstract available.
References
REFERENCES
-
- Mahaut-Smith MP. The unique contribution of ion channels to platelet and megakaryocyte function. J Thromb Haemost. 2012;10(9):1722-1732. doi:10.1111/j.1538-7836.2012.04837.x
-
- Dionisio N, Redondo P, Jardin I, Rosado JA. Transient receptor potential channels in human platelets: expression and functional role. Curr Mol Med. 2012;12(10):1319-1328.
-
- Mahaut-Smith MP. Calcium-activated potassium channels in human platelets. J Physiol. 1995;484(1):15-24. doi:10.1113/jphysiol.1995.sp020644
-
- Fine BP, Hansen KA, Salcedo JR, Aviv A. Calcium-activated potassium channels in human platelets. Proc Soc Exp Biol Med. 1989;192(2):109-113.
-
- Senis YA, Tomlinson MG, García Á, et al. A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel Immunoreceptor tyrosine-based inhibitory motif protein. Mol Cell Proteomics. 2007;6(3):548-564. doi:10.1074/mcp.D600007-MCP200
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
